Although critical for Treg maturation and normal suppressive activity, aberrantly high CD27 levels in Tregs could potentially inhibit effective anti‐tumor immune responses.[19] Co‐stimulatory genes demonstrated significant enrichment within invasive front and tumor core regions across spatial transcriptomic datasets (Figure 2D; Table S3, Supporting Information). The gene discussed is CD27; the disease is neoplasm.